Similar Papers

Paper Title
Journal
Date
Author
Transcriptional Repression of Bim by a Novel YY1-RelA Complex Is Essential for the Survival and Growth of Multiple Myeloma
Veena Potluri ... Sivakumar Vallabhapurapu
PLoS ONE | VOL. 8
Veena Potluri, et. al.Veena Potluri ... Sivakumar Vallabhapurapu
10 Jul 2013
Androgen Receptor Overexpression in Prostate Cancer Linked to Purα Loss from a Novel Repressor Complex
Longgui G Wang ... Ralf Kurek
Cancer Research | VOL. 68
Longgui G Wang, et. al.Longgui G Wang ... Ralf Kurek
15 Apr 2008
The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex
Wenxiang Zhang ... Lei Zhang
Journal of Biological Chemistry | VOL. 293
Wenxiang Zhang, et. al.Wenxiang Zhang ... Lei Zhang
01 Nov 2018
Targeting aberrant transcriptional repression in leukemia: a therapeutic reality?
Jonathan D Licht
Journal of Clinical Investigation | VOL. 108
Jonathan D LichtJonathan D Licht
01 Nov 2001
View more papers

More From: Clinical Lymphoma, Myeloma and Leukemia

Paper Title
Journal
Date
Author
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
Andrew H Lipsky ... Nicole Lamanna
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Andrew H Lipsky, et. al.Andrew H Lipsky ... Nicole Lamanna
01 Dec 2024
Table of Contents
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
A phase I study of romidepsin in combination with gemcitabine, oxaliplatin, and dexamethasone in patients with relapsed or refractory aggressive lymphomas enriched for T-cell lymphomas.
Nicole Foley ... Neha Mehta-Shah
Clinical Lymphoma, Myeloma and Leukemia | VOL. -
Nicole Foley, et. al.Nicole Foley ... Neha Mehta-Shah
01 Dec 2024
Editorial Board
-
Clinical Lymphoma, Myeloma and Leukemia | VOL. 24
--
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.